In early February, when former President Donald Trump revealed “TrumpRx,” it felt like a huge weight had been lifted off my shoulders. This initiative promises to align prescription drug costs in the U.S. with those in other developed nations, making life-saving medications far more affordable. As someone who has battled chronic illness, I can personally vouch for the necessity of such a shift, often referred to as “most-favored-nation” pricing.
I’ve struggled with asthma since I was a child. Thankfully, prescription medications helped manage my situation, but there have been moments — too many, really — when I stopped taking them and ended up in emergency rooms gasping for breath. A particularly tense episode unfolded four years ago during a trip overseas, in a situation I’d never want to find myself in again: I was away from home, with no local doctor or pharmacy nearby.
We were in Italy, on a journey to honor my mother, who had just been diagnosed with cancer. My brother and I had planned the trip to coincide with her chemotherapy treatments. She had always dreamed of visiting Italy with us. But in my rush to pack, I mistakenly grabbed an inhaler that was nearly empty.
A few days into our trip, panic set in when I realized that I had only two doses left. Honestly, I was worried about my health, of course, but there were other concerns too—like how I would afford another inhaler if I found it in Italy.
I had tailored my work life around getting insurance that covered my medications, especially since, for many years, the retail cost was about $600 monthly. For over two decades, denied claims and high-priced prescriptions have been the norm for me, leaving me anxious about cutting back on necessities just to afford my meds. Back then, Italians were paying hundreds of dollars for the same drug, which, while pricey, was a comparative bargain.
It was a risk I had to take; I had to find my medication. After a brief search, I discovered a pharmacy across town. As I headed there, all sorts of anxious thoughts raced through my mind. What if I couldn’t find my medicine? What would that mean for getting back home safely?
Fifteen minutes later, I stepped out, tears in my eyes and medicine in hand. The cost? Just 30 euros, or roughly $35.
Initially, I was both relieved and grateful. Yet, by day’s end, I found myself pondering, Why was the price $600 in the U.S. when I could get it for almost nothing in Italy? As it turns out, the explanation is quite complex.
Various factors contribute, from a lack of price transparency to intermediaries who jack up costs. Other countries have negotiated drug prices for decades, effectively forcing Americans to bear the brunt of drug development costs while enjoying lower prices elsewhere.
Whatever the underlying issues, the current system isn’t working for us. In fact, brand-name prescriptions in the U.S. cost more than four times the price in other wealthy nations. Over the years, around 18 million Americans have struggled with the high costs of necessary prescriptions.
At present, I’m on a much cheaper generic medication, but that doesn’t erase the years I’ve spent overpaying for my prescriptions. It’s a stark contrast to how effortlessly I found my medication in Italy.
Trump is determined to fix this flawed system. Before launching TrumpRx, he negotiated 16 agreements with pharmaceutical companies to ensure most-favored-nation pricing. I tend to feel uneasy about government interventions in the market, as a lifelong conservative. Yet, it seems clear that other countries have stepped in, and individuals like myself are left to pay the price.
If pharmaceutical companies need extra funds, they should collaborate with those countries they initially struck deals with to secure that money. It seems only fair that the cost shouldn’t solely fall on U.S. consumers while others take advantage of negotiated pricing. It feels unjust for 340 million Americans to pay so much more than countless others living in Europe and Asia.
I will always cherish the fact that I was able to afford my medication in Italy in 2022. It might have saved my life. But what I’m even more grateful for is how President Trump is working to bring down drug prices for all Americans.
